搜索临床试验以:HER-2 Positive Breast Cancer
总计132468个结果
-
University of WashingtonNational Cancer Institute (NCI)终止
-
Jin-Hee AhnAsan Medical Center未知HER-2基因扩增 | HER-2 蛋白过表达
-
Orum Therapeutics USA, Inc.招聘中
-
Mayo ClinicMarker Therapeutics, Inc.完全的HER2阳性乳腺癌 | 男性乳腺癌 | II期乳腺癌 | IIIA期乳腺癌 | IIIB期乳腺癌 | IIIC期乳腺癌美国
-
Tianjin Medical University Second HospitalJiangsu HengRui Medicine Co., Ltd.未知
-
Chinese PLA General Hospital未知
-
University of WashingtonNational Cancer Institute (NCI)完全的
-
Memorial Sloan Kettering Cancer CenterNational Institutes of Health (NIH)招聘中
-
Washington University School of MedicineMolecular Templates, Inc.撤销HER2阳性实体瘤 | HER-2阳性癌症
-
Bellicum Pharmaceuticals暂停HER2阳性乳腺癌 | HER2阳性胃癌 | 实体瘤,成人 | HER-2基因扩增 | HER-2 蛋白过表达美国
-
University of WashingtonNational Cancer Institute (NCI)完全的HER2阳性乳腺癌 | 男性乳腺癌 | IV 期乳腺癌 | II期乳腺癌 | IIIA期乳腺癌 | IIIB期乳腺癌 | IIIC期乳腺癌 | 复发性乳腺癌美国
-
University of WashingtonNational Cancer Institute (NCI)完全的
-
University of WashingtonNational Cancer Institute (NCI)撤销
-
H. Lee Moffitt Cancer Center and Research Institute终止乳腺癌 | 乳腺癌,男性 | HER2阳性乳腺癌 | HER-2基因扩增 | 乳腺癌女性 | HER2阳性乳腺癌 | HER-2 蛋白过表达美国
-
Ontario Clinical Oncology Group (OCOG)Canadian Breast Cancer Research Alliance; Ontario Cancer Research Network完全的
-
University of Alabama at BirminghamNational Cancer Institute (NCI)撤销乳腺癌 | 胃癌 | 卵巢癌 | 肺癌 | 未明确的成人实体瘤,特定方案
-
University of PennsylvaniaAbramson Cancer Center of the University of Pennsylvania不再可用
-
H. Lee Moffitt Cancer Center and Research InstituteAbramson Cancer Center at Penn Medicine完全的
-
Sichuan Baili Pharmaceutical Co., Ltd.招聘中
-
Instituto Nacional de Cancerologia de Mexico完全的
-
Hospices Civils de Lyon尚未招聘
-
Jules Bordet InstituteGlaxoSmithKline; Schering-Plough完全的
-
Medstar Health Research InstituteGenentech, Inc.终止
-
ASLAN Pharmaceuticals完全的
-
Craig L Slingluff, JrNational Cancer Institute (NCI)完全的
-
H. Lee Moffitt Cancer Center and Research Institute主动,不招人
-
Nanjing Chia-tai Tianqing Pharmaceutical招聘中
-
Tianjin Medical University Cancer Institute and...招聘中
-
Istituto Scientifico Romagnolo per lo Studio e...完全的
-
Puma Biotechnology, Inc.终止转移性宫颈癌 | 激素受体阳性、HER2 阴性的转移性乳腺癌西班牙, 以色列, 美国, 塞尔维亚, 法国, 爱尔兰, 意大利